Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
108 participants
INTERVENTIONAL
2007-08-31
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Double-blind Randomized Controlled Trial of a Thickened Amino-acid-based Formula in Children Allergic to Cow's Milk and to Protein Hydrolysates
NCT01940068
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
NCT02450643
Evaluation of the Efficacy of a New Formula in Infants With Cow's Milk Protein Allergy
NCT01998074
Infant Formula in Infants and Children With Cow's Milk Allergy
NCT06456541
Growth, Safety and Tolerance of a Hydrolyzed Protein Infant Formula
NCT05618704
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Extensively hydrolyzed infant formula
New extensively hydrolyzed formula, NPS-202
Nutramigen Lipil (Infant formula)
Infant formula - Extensively hydrolyzed Nutramigen Lipil
Currently marketed extensively hydrolyzed formula (Nutramigen Lipil)
Nutramigen Lipil (Infant formula)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nutramigen Lipil (Infant formula)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \</= 12 weeks at time of study entry
* full-term infant
* must be willing to use provided formula as sole source of nutrition
* other than CMA, infant must be otherwise healthy
Exclusion Criteria
* infants born from an addictive situation, HIV positive
* if parent/guardian is considered likely to be non-compliant with the protocol requirements
1 Day
12 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Perrigo Nutritionals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
PBM Products, LLC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cynthia M Barber, PhD
Role: STUDY_DIRECTOR
Perrigo Nutritionals
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTP-0010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.